MMV533 Plasmodium Falciparum Volunteer Infection Study

NCT05205941 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: MMV688533

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]
[object Object]